Rami Levin
Amministratore Delegato presso ImStem Biotechnology, Inc.
Profilo
Rami Levin is currently the Chief Executive Officer at ImStem Biotechnology, Inc. and also holds a position at Swedish Orphan Biovitrum, Inc. as President.
Prior to his current roles, he served as the President & Chief Executive Officer at Saniona AB from 2020 to 2022.
He also held positions at EMD Serono, Inc. as Vice President-Marketing and at Swedish Orphan Biovitrum AB as Head-North America.
Mr. Levin received his undergraduate degree from Tel-Aviv University and his MBA from Recanati Business School Tel Aviv University.
Posizioni attive di Rami Levin
| Società | Posizione | Inizio |
|---|---|---|
ImStem Biotechnology, Inc.
 ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Amministratore Delegato | 02/09/2022 |
Precedenti posizioni note di Rami Levin
| Società | Posizione | Fine |
|---|---|---|
| SANA AB | Amministratore Delegato | 30/04/2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | - |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Presidente | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Vendite & Marketing | - |
Formazione di Rami Levin
| Tel-Aviv University | Undergraduate Degree |
| Recanati Business School Tel Aviv University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| SANA AB | Health Technology |
| Aziende private | 3 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
ImStem Biotechnology, Inc.
ImStem Biotechnology, Inc. Medical SpecialtiesHealth Technology ImStem Biotechnology, Inc. operates as a biotechnology company. It focuses on developing cell therapeutic products. Its cell therapeutic products are derived from human pluripotent stem cells for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. The company was founded by Xinghua Victor Pan, Ren-He Xu, Michael Men, and Xiaofang Wang in June 2012 and is headquartered in Farmington, CT. | Health Technology |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Rami Levin
